We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Zentalis Pharmaceuticals
ZNTL
$308M
| $947K | ﹤0.01% |
14,218
-1,830
| -11% | -$106K |
|
927
RingCentral
RNG
$4.05B
| $946K | ﹤0.01% |
4,348
+54
| +1% | +$13.7K |
|
928
Primerica
PRI
$9.81B
| $941K | ﹤0.01% |
6,126
-241
| -4% | -$35.9K |
|
|
FLG
929
Flagstar Bank National Association
FLG
$5.77B
| $930K | ﹤0.01% |
24,097
-916
| -4% | -$33.2K |
|
930
Myriad Genetics
MYGN
$530M
| $924K | ﹤0.01% |
28,627
-7,173
| -20% | -$238K |
|
931
Simpson Manufacturing
SSD
$7.98B
| $919K | ﹤0.01% |
8,589
-5,996
| -41% | -$664K |
|
|
HRC
932
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $917K | ﹤0.01% |
6,113
-1,318
| -18% | -$178K |
|
933
Pacira BioSciences
PCRX
$1.02B
| $909K | ﹤0.01% |
16,237
-4,194
| -21% | -$242K |
|
934
Amkor Technology
AMKR
$16.1B
| $908K | ﹤0.01% |
36,387
+1,783
| +5% | +$45.5K |
|
935
Radian Group
RDN
$5.14B
| $907K | ﹤0.01% |
39,907
-26,386
| -40% | -$599K |
|
936
Exponent
EXPO
$2.98B
| $905K | ﹤0.01% |
8,000
-6,891
| -46% | -$743K |
|
937
ACI Worldwide
ACIW
$5.72B
| $903K | ﹤0.01% |
29,401
-16,438
| -36% | -$545K |
|
|
SWTX
938
DELISTED
SpringWorks Therapeutics
SWTX
| $903K | ﹤0.01% |
14,237
-2,153
| -13% | -$166K |
|
939
ImmunityBio
IBRX
$7.44B
| $899K | ﹤0.01% |
92,314
+5,983
| +7% | +$65.8K |
|
940
SPS Commerce
SPSC
$2.25B
| $895K | ﹤0.01% |
5,550
-4,786
| -46% | -$590K |
|
|
CHX
941
DELISTED
ChampionX
CHX
| $893K | ﹤0.01% |
39,941
-26,830
| -40% | -$613K |
|
942
PTC Therapeutics
PTCT
$6.37B
| $893K | ﹤0.01% |
23,989
-6,689
| -22% | -$275K |
|
943
DT Midstream
DTM
$14.9B
| $892K | ﹤0.01% |
+19,288
| New | +$844K |
|
944
Federated Hermes
FHI
$4.4B
| $887K | ﹤0.01% |
27,301
-12,360
| -31% | -$403K |
|
|
APLS
945
DELISTED
Apellis Pharmaceuticals
APLS
| $886K | ﹤0.01% |
26,894
-4,419
| -14% | -$248K |
|
|
HPP
946
Hudson Pacific Properties
HPP
$834M
| $881K | ﹤0.01% |
4,789
-53
| -1% | -$9.99K |
|
|
TGNA
947
DELISTED
TEGNA Inc
TGNA
| $881K | ﹤0.01% |
44,689
-30,396
| -40% | -$552K |
|
948
WillScot Mobile Mini Holdings
WSC
$4.8B
| $881K | ﹤0.01% |
27,765
-20,722
| -43% | -$599K |
|
949
BioCryst Pharmaceuticals
BCRX
$2.37B
| $877K | ﹤0.01% |
60,998
-17,056
| -22% | -$269K |
|
950
Acadia Pharmaceuticals
ACAD
$4.25B
| $871K | ﹤0.01% |
52,428
-11,630
| -18% | -$224K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.